Mito-FLAG regimen

Revision as of 17:30, 27 March 2015 by Aparna Vuppala (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Mito-FLAG regimen

Articles

Most recent articles on Mito-FLAG regimen

Most cited articles on Mito-FLAG regimen

Review articles on Mito-FLAG regimen

Articles on Mito-FLAG regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mito-FLAG regimen

Images of Mito-FLAG regimen

Photos of Mito-FLAG regimen

Podcasts & MP3s on Mito-FLAG regimen

Videos on Mito-FLAG regimen

Evidence Based Medicine

Cochrane Collaboration on Mito-FLAG regimen

Bandolier on Mito-FLAG regimen

TRIP on Mito-FLAG regimen

Clinical Trials

Ongoing Trials on Mito-FLAG regimen at Clinical Trials.gov

Trial results on Mito-FLAG regimen

Clinical Trials on Mito-FLAG regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mito-FLAG regimen

NICE Guidance on Mito-FLAG regimen

NHS PRODIGY Guidance

FDA on Mito-FLAG regimen

CDC on Mito-FLAG regimen

Books

Books on Mito-FLAG regimen

News

Mito-FLAG regimen in the news

Be alerted to news on Mito-FLAG regimen

News trends on Mito-FLAG regimen

Commentary

Blogs on Mito-FLAG regimen

Definitions

Definitions of Mito-FLAG regimen

Patient Resources / Community

Patient resources on Mito-FLAG regimen

Discussion groups on Mito-FLAG regimen

Patient Handouts on Mito-FLAG regimen

Directions to Hospitals Treating Mito-FLAG regimen

Risk calculators and risk factors for Mito-FLAG regimen

Healthcare Provider Resources

Symptoms of Mito-FLAG regimen

Causes & Risk Factors for Mito-FLAG regimen

Diagnostic studies for Mito-FLAG regimen

Treatment of Mito-FLAG regimen

Continuing Medical Education (CME)

CME Programs on Mito-FLAG regimen

International

Mito-FLAG regimen en Espanol

Mito-FLAG regimen en Francais

Business

Mito-FLAG regimen in the Marketplace

Patents on Mito-FLAG regimen

Experimental / Informatics

List of terms related to Mito-FLAG regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

Mito-FLAG regimen refers to a regimen consisting of mitoxantrone, fludarabine, cytarabine as bolus (B) or continuous infusion (CI) and granulocyte- colony stimulating factor (G-CSF) in patients with recurrent and refractory acute myeloid leukemia (AML).[1]

Regimen

MitoMitoxantrone

FLFludarabine

ACytarabine (AraC)

GGranulocyte- colony stimulating factor

Indications

References

  1. 1.0 1.1 Hänel M, Friedrichsen K, Hänel A, Herbst R, Morgner A, Neser S; et al. (2001). "Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia". Onkologie. 24 (4): 356–60. doi:55107 Check |doi= value (help). PMID 11574763.